Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||0.00%||8.00||0.7%||$559.23m|
|GILD||Gilead Sciences, Inc.||-0.29%||64.70||1.0%||$471.04m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.51%||479.47||2.7%||$433.31m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.07%||216.10||1.9%||$372.34m|
|ALXN||Alexion Pharmaceuticals, Inc.||0.00%||153.73||2.0%||$315.33m|
|EXAS||EXACT Sciences Corp.||1.48%||129.89||18.4%||$197.74m|
|NBIX||Neurocrine Biosciences, Inc.||0.00%||92.97||4.9%||$172.50m|
|CRSP||CRISPR Therapeutics AG||0.40%||121.36||0.6%||$170.02m|
Seagen Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.